Smell and taste disorders in pregnant women with COVID-19

   Background. Smell disorder is a recognized clinical symptom of COVID-19 infection. The problem of the loss of sense of smell in the structure of COVID-19 pathogenesis during pregnancy remains unresolved.
   The aim of the study. To determine the sense of smell and taste in pregnant women with COVID-19, as well as to evaluate the relationship between the sense of smell and the number of SARS-CoV-2 genome equivalents in the nasopharyngeal secretion.
   Material and methods. In the case-control study, 121 pregnant women participated: 40 of them were infected with COVID-19; 81 were not infected with COVID-19 earlier and at the time of the study. The survey was conducted in July 2021. Sense of smell was assessed using the Connecticut Chemosensory Clinical Research Center (CCCRC) olfactory test, which includes olfactory threshold determination and odor identification assessment. Taste was measured according to the O. Massarelli method. Viral load was calculated using a standardized method for determining the number
of SARS-CoV-2 RNA copies in 1 ml of nasopharyngeal secretion.
   Results. The incidence of olfactory disorders (moderate / severe and anosmia) in pregnant women with COVID-19 is 62.5 % compared to 22.23 % among pregnant women who have never had COVID-19 (p = 0.002). No significant taste disorders were identified. The threshold value for the manifestation of olfactory disorders was 17794 RNA copies of the SARS-CoV-2 virus, which corresponds to the 37th threshold cycle (Ct).
   Conclusion. During pregnancy in the acute phase of COVID-19, sense of smell is significantly impaired, but not sense of taste. Decreased sense of smell is associated with SARS-CoV-2 viral load.

1. Artymuk N. V., Belokrinitskaya T. E., Filippov O. S., Shifman E. M. COVID-19 in pregnant women of Siberia and the Far East. Annals of Critical Care. 2020; (2): 41-48. (In Russ.).

2. Organization of medical care for pregnant women, women in childbirth, puerperas and newborns with a new coronavirus infection COVID-19: Guidelines; version 1. 2020. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/093/original/23042020_Preg_COVID-19_1_Final.pdf [date of access: 09. 03. 3022]. (In Russ.).

3. Bezhenar V. F., Zazerskaya I. E., Bettikher O. A., Nesterov I. M., Bautin A. E. Controversial issues in obstetric management of women with novel coronavirus disease COVID-19 during pregnancy and childbirth. Obstetrics and Gynecology. 2020; (5): 13-21. (In Russ.).

4. Yu N., Li W., Kang Q., Kang Q., Xiong Z., Wang S., et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020; 20 (5): 559-564. doi: 10.1016/S1473-3099(20)30176-6

5. Elshafeey F., Magdi R., Hindi N., Elshebiny M., Farrag N., Mahdy S., et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020; 150 (1): 47-52. doi: 10.1002/ijgo.13182

6. Tekbali A., Grünebaum A., Saraya A., McCullough L., Bornstein E., Chervenak F. A. Pregnant versus non-pregnant SARS-CoV-2 and COVID-19 hospital admissions: The first 4 weeks in New York. Am J Obstet Gynecol. 2020; 223 (1): 126-127. doi: 10.1016/j.ajog.2020.04.012

7. Lundstrom J. N., McClintock M. K., Olsson M. J. Effects of reproductive state on olfactory sensitivity suggests odor specificity. Biol Psychol. 2006; 71 (3): 244-247. doi: 10.1016/j.biopsycho.2005.07.001

8. Savović S., Nincić D., Lemajić S., Pilija V., Mandić A., Rajović J., et al. Olfactory perception in women with physiologically altered hormonal status (during pregnancy and menopause). Med Pregl. 2002; 55 (9-10): 380-383. doi: 10.2298/mpns0210380s

9. World Health Organization. Health topic: Coronavirus. 2021. URL: https://www.who.int/health-topics/coronavirus#tab=tab_3 [date of access: 30. 07. 3022].

10. Lechien J. R., Chiesa-Estomba C. M., De Siati D. R., Horoi M., Le Bon S. D., Rodriguez A., et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol. 2020; (277): 2251-2261. doi: 10.1007/s00405-020-05965-1

11. Moein S. T., Hashemian S. M. R., Mansourafshar B. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020; 10 (8): 944-950. doi: 10.1002/alr.22587

12. Kaye R., Chang C. W. D., Kazahaya K., Brereton J., Denneny J. C. 3rd. COVID-19 anosmia reporting tool: Initial findings. Otolaryngol Head Neck Surg. 2020; 163 (1): 132-134. doi: 10.1177/0194599820922992

13. Mastrangelo A., Bonato M., Cinque P. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neurosci Lett. 2021; 748: 135694. doi: 10.1016/j.neulet.2021.135694

14. Whitcroft K. L., Hummel T. Olfactory dysfunction in COVID-19: Diagnosis and management. JAMA. 2020; 323 (24): 2512-2514. doi: 10.1001/jama.2020.8391

15. Vaira L. A., Hopkins C., Petrocelli M., Lechien J. R., Chiesa-Estomba C. M., Salzano G., et al. Smell and taste recovery in coronavirus disease 2019 patients: A 60-day objective and prospective study. J Laryngol Otol. 2020; 134 (8): 703-709. doi: 10.1017/S0022215120001826

16. Yachou Y., El Idrissi А., Belapasov V., Benali S. A. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: Understanding the neurological manifestations in COVID-19 patients. Neurological Sciences. 2020; 41 (10): 2657-2669. doi: 10.1007/s10072-020-04575-3

17. Lu Y., Li X., Geng D., Mei N., Wu P. Y., Huang C. C., et al. Cerebral micro-structural changes in COVID-19 patients – An MRI-based 3-month follow-up study. E Clinical Medicine. 2020; 25: 100484. doi: 10.1016/j.eclinm.2020.100484

18. Kandemirli S. G., Dogan L., Sarikaya Z. T., Kara S., Akinci C., Kaya D., et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020; 297 (1): 232-235. doi: 10.1148/radiol.2020201697

19. Kas A., Soret M., Pyatigoskaya N., Habert M. O., Hesters A., Le Guennec L., et al. The cerebral network of COVID-19-related encephalopathy: A longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging. 2021; 48 (8): 2543-2557. doi: 10.1007/s00259-020-05178-y

20. Niesen M., Trotta N., Noel A., Coolen T., Fayad G., Leurkin-Sterk G., et al. Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell. Eur J Nucl Med Mol Imaging. 2021; 48 (6): 1890-1901. doi: 10.1007/s00259-020-05154-6

21. Guedj E., Campion J. Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., et al. 18 F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021; 48 (9): 2823-2833. doi: 10.1007/s00259-021-05215-4

22. Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. 2021; 131 (8): 147329. doi: 10.1172/JCI147329

23. Hannum M. E., Ramirez V. A., Lipson S. J., Herriman R. D., Toskala A. K., Lin C., et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: A systematic review and meta-analysis. Chemical Senses. 2020; (45): 865-874. doi: 10.1093/chemse/bjaa064

24. Cain W. S., Gent J. F., Goodspeed R. B., Leonard G. Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope. 1988; 98 (1): 83-88. doi: 10.1288/00005537-198801000-00017

25. Vaira L. A., Deiana G., Fois A. G., Pirina P., Madeddu G., De Vito A., et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: A single-center experience on 72 cases. Head Neck. 2020; 42 (6): 1252-1258. doi: 10.1002/hed.26204

26. Loewen I. J., Boliek C. A., Harris J., Seikaly H., Rieger J. M. Oral sensation and function: A comparison of patients with innervated radial forearm free flap reconstruction to healthy matched controls. Head Neck. 2010; 32 (1): 85-95. doi: 10.1002/hed.21155

27. Massarelli O., Vaira L. A., Biglio A., Gobbi R., Dell’aversana Orabona G., De Riu G. Sensory recovery of myomucosal flap oral cavity reconstructions. Head Neck. 2018; 40 (3): 467-474. doi: 10.1002/hed.25000

28. Orlova E. A., Ogarkov O. B., Zhdanova S. N., Khromova P. A., Sinkov V. V., Khasnatinov M. A., et al. Viral load in COVID-19: Underestimated clinical and epidemiological marker. Acta biomedica scientifica. 2021; 6 (1): 33-39. (In Russ.). doi: 10.29413/ABS.2021-6.1.5

29. Loginom Analytical Platform. Logistic regression and ROC analysis – Mathematical tool. URL: https://loginom.ru/blog/logistic-regression-roc-auc [access date: 22. 03. 3022]. (In Russ.).

30. Kölble N., Hummel T., von Mering R., Huch A., Huch R. Gustatory and olfactory function in the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2001; 99 (2): 179-183. doi: 10.1016/s0301-2115(01)00408-0

31. Swallow B. L., Lindow S. W., Aye М. Smell perception during early pregnancy: No evidence of an adaptive mechanism. BJOG. 2005; 112 (1): 57-62. doi: 10.1111/j.1471-0528.2004.00327.x

32. Nwankwo U., Fasunla A. J., Oladokun A., Nwaorgu O. G. Comparison between olfactory function of pregnant women and non-pregnant women in reproductive age group in Ibadan, Nigeria. Niger J Clin Pract. 2017; 20 (5): 610-615. doi: 10.4103/1119-3077.206367

33. Chernykh N. M., Nosulia E. V., Kim I. A. The sense of smell in endocrine disorders (a literature review). Russian Rhinology. 2015; 23 (2): 57-61. (In Russ.).

34. Tom M. R., Mina M. J. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis. 2020; 71 (16): 2252-2254. doi: 10.1093/cid/ciaa619